Companies: 10,795·Total market cap: $144.5T
Cantabio Pharmaceuticals, Inc.

Cantabio Pharmaceuticals, Inc.

CTBOOTCHealthcare● Active
$1.01
+$0.00(+0.00%)
Market Cap$22769
P/E Ratio—
52W High$1.01
52W Low$1.01
Overview

Cantabio Pharmaceuticals, Inc. (CTBO) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

CTBO · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
No earnings history available.
No analyst estimates available for CTBO.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: CTBO ends December

Cantabio Pharmaceuticals, Inc. (CTBO) reports earnings quarterly as a OTC-listed Biotechnology company. The next CTBO earnings date is expected around September 1, 2026.

Each quarter, investors track CTBO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CTBO revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CTBO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

CTBO earnings · 3 questions

Cantabio Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. CTBO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CTBO historically reports after market close (AMC).

CTBO earnings datewhen is CTBO earningsCTBO next earnings datewhen does CTBO report earningsCTBO earnings calendar

▸ Source: FMP · Cantabio Pharmaceuticals, Inc. SEC filings · US GAAP · Cantabio Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026